LB Pharmaceuticals names Christopher Zergebel as SVP of clinical ops
Go back to LB Pharmaceuticals names Christopher Zergebel as SVP of clinical ops| (NASDAQ: LBRX) | Delayed: 36.77 -0.56 (1.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.33 | 52 Week High | $ | |||
| Open | $37.24 | 52 Week Low | $ | |||
| Day High | $37.49 | P/E | N/A | |||
| Day Low | $36.69 | EPS | $ | |||
| Volume | 16,547 | |||||
